BIMI International Medical Inc.
BIMI · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | 0.00 | -0.00 |
| FCF Yield | -206.79% | -88.64% | 1,336.28% | -892.39% |
| EV / EBITDA | -1.45 | 2.45 | -4.74 | -0.44 |
| Quality | ||||
| ROIC | -18.66% | 6.78% | 3.61% | -57.24% |
| Gross Margin | 4.56% | 51.89% | 52.85% | 142.67% |
| Cash Conversion Ratio | 0.49 | -0.21 | -3.19 | 0.25 |
| Growth | ||||
| Revenue 3-Year CAGR | -42.48% | -19.03% | -18.44% | -8.81% |
| Free Cash Flow Growth | -266.01% | -120.24% | 196.33% | 64.69% |
| Safety | ||||
| Net Debt / EBITDA | -1.12 | 1.94 | -4.47 | -0.40 |
| Interest Coverage | -87.80 | 37.53 | 16.45 | -2.38 |
| Efficiency | ||||
| Inventory Turnover | 0.34 | 0.37 | 0.18 | -0.41 |
| Cash Conversion Cycle | 67.40 | 36.69 | 38.88 | 21.35 |